DEXILANT

This brand name is authorized in Brazil, Canada, Germany, Ecuador, Hong Kong, Israel, Lithuania, Poland, Singapore, United States

Active ingredients

The drug DEXILANT contains one active pharmaceutical ingredient (API):

1 Dexlansoprazole UNII UYE4T5I70X - DEXLANSOPRAZOLE

Dexlansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H+, K+)-ATPase at the secretory surface of the gastric parietal cell. Read about Dexlansoprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEXILANT Delayed-release capsules	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC06	Dexlansoprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501112070019102, 501112070019202, 501112070019302, 501112070019402, 501112070019502, 501112070019602, 501112070019702, 501112070019802
Country: CA	Health Products and Food Branch	Identifier(s): 02354950, 02354969
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10358180, 10358197, 10358205, 10358211
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 42-MEE-0114, 74-MEE-0214
Country: HK	Department of Health Drug Office	Identifier(s): 61372, 61373
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7911, 7912
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1065692, 1065693, 1071852, 1071853, 1075642, 1075643, 1083392, 1083393, 1083394, 1083395, 1084821, 1084822, 1088119, 1088120, 1089400, 1089401, 1089402, 1089403, 1089643, 1089644
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100306888, 100306894
Country: SG	Health Sciences Authority	Identifier(s): 14485P, 14486P
Country: US	FDA, National Drug Code	Identifier(s): 50090-4374, 55154-5154, 64764-171, 64764-175